PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Chart, page-2256

  1. 792 Posts.
    lightbulb Created with Sketch. 162
    However, the annual report is due at the end of this month, so I would assume some sort of update may be given by the company regarding the state of the submission to the FDA at this time.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.